LOS ANGELES, CA — May 3, 2002 — Researchers at Cedars-Sinai Medical Center report that treatment with

NEW YORK (Reuters Health) May 01 – The phenylalkylamine calcium antagonist verapamil and the dihydropyridine calcium antagonists

By Bruce Sylvester Special to DG News CHICAGO, IL — May 3, 2002 — Type 2 diabetics

WASHINGTON (Reuters Health) Apr 29 – Drugmaker Pfizer Inc. said on Monday that it has received approval

For the first time, women have a birth control option they only need to think about once-a-week

NEW YORK (Reuters Health) Apr 26 – A delayed prescription strategy can significantly reduce antibiotic use by

NEW YORK (Reuters Health) Apr 29 – Results of a randomized trial show that transdermal administration of

NEW YORK (Reuters Health) Apr 29 – The results of a meta-analysis of cohort and case control

British Journal of Dermatology 04/25/2002 By James Adams Sixty-day treatment with 3.0% diclofenac in 2.5% hyaluronan gel

KENILWORTH, NJ — April 25, 2002 — Schering-Plough Corporation today announced that the European Commission of the